D. E. Shaw & Co., Inc. Celldex Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 406,161 shares of CLDX stock, worth $9.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

406,161

Previous 518,340 21.64%

Holding current value

$9.48 Million

Previous $13.1 Million 43.72%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$18.15 - $27.6 $2.04 Million - $3.1 Million	-112,179 Reduced 21.64%	406,161 $7.37 Million
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $7.15 Million - $9.94 Million	-306,777 Reduced 37.18%	518,340 $13.1 Million
Q3 2024 Nov 14, 2024	SELL	$32.06 - $44.56 $655,402 - $910,940	-20,443 Reduced 2.42%	825,117 $28 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $8.92 Million - $11.6 Million	272,389 Added 47.52%	845,560 $31.3 Million
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $19.4 Million - $28.5 Million	549,425 Added 2313.76%	573,171 $24.1 Million
Q4 2023 Feb 14, 2024	SELL	$22.61 - $40.65 $294,789 - $529,994	-13,038 Reduced 35.44%	23,746 $941,000
Q3 2023 Nov 14, 2023	BUY	$25.45 - $37.46 $195,965 - $288,442	7,700 Added 26.48%	36,784 $1.01 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $76,754 - $97,001	2,534 Added 9.54%	29,084 $986,000
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $137,520 - $187,538	-3,954 Reduced 12.96%	26,550 $955,000
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $2.17 Million - $3.55 Million	-78,161 Reduced 71.93%	30,504 $1.36 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $750,348 - $1.24 Million	-33,055 Reduced 23.32%	108,665 $3.06 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $400,734 - $729,726	19,548 Added 16.0%	141,720 $3.82 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $1.45 Million - $2.07 Million	-52,613 Reduced 30.1%	122,172 $4.16 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $2.17 Million - $3.42 Million	60,861 Added 53.42%	174,785 $6.75 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $2.42 Million - $4.68 Million	83,625 Added 276.0%	113,924 $6.15 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $627,492 - $1.07 Million	30,299 New	30,299 $1.01 Million
Q4 2019 Feb 14, 2020	SELL	$2.11 - $2.8 $35,277 - $46,813	-16,719 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.75 $5,944 - $7,975	-2,900 Reduced 14.78%	16,719 $36,000
Q2 2019 Aug 14, 2019	SELL	$2.43 - $5.09 $209,130 - $438,055	-86,062 Reduced 81.44%	19,619 $53,000
Q1 2019 May 15, 2019	BUY	$3.45 - $10.35 $364,599 - $1.09 Million	105,681 New	105,681 $520,000

Others Institutions Holding CLDX

# of Institutions

189

Shares Held

69.3M

Call Options Held

220K

Put Options Held

310K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.09B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account